(Date:11/21/2008)... Texas Monthly Magazine announced its no...quot; award given to elite dentists in Texas. Dr. ...n nominated a top practitioner in the area of Cosm... TX (PRWEB) November 21, 2008-- Dr. Michael McCart...quot;Texas Monthly Super Dentist" for the thi...
(Date:11/20/2008)...at timing is everything, and that certainly appear...born four months before the height of cold and flu...d asthma than children born at any other time of y...lyzed the birth and medical records of more than 9...etermine whether date of birth in relationship to ...
(Date:11/20/2008)..., DC (November 20, 2008) While the U.S. AIDS epide... failure to widely implement routine HIV testing c...xperts said today. Almost 60,000 Americans were in...70 percent of new sexually transmitted infections ...cted. ,Guidelines issued two years ago by the U....
(Date:11/20/2008)...0 ReachMD, the first satellite rad...edical professionals, announced,today their newes...can Medical,Directors Association (AMDA), the pro...ding physicians, and others practicing in the long...celius, President of AMDA says, "ReachMD provides ...
Breaking Medicine News(10 mins):Health News:Texas Super Dentist Awards Announced--Dr. Michael McCarty From Austin Smiles Is Awarded For The Third Year In A Row 2Health News:Fall babies: Born to wheeze? 2Health News:Despite national guidelines, private insurers, ER, federal and state agencies fail to routinely test for HIV 2Health News:Despite national guidelines, private insurers, ER, federal and state agencies fail to routinely test for HIV 3Health News:Despite national guidelines, private insurers, ER, federal and state agencies fail to routinely test for HIV 4Health News:Despite national guidelines, private insurers, ER, federal and state agencies fail to routinely test for HIV 5Health News:ReachMD Announces New Strategic Partnership with American Medical Directors Association 2(Date:11/13/2008)... BEDFORD, Mass., Nov. 13 /PRNewswire-FirstCal...veloper, manufacturer and supplier of premium,diag...ucts dedicated to,serving the healthcare needs of ... HPV high-risk pivotal clinical trial. The Cervist...the FDA in the U.S. and is expected to be,launched...
(Date:11/12/2008)... NEW YORK, Nov. 12 ...ne edition of Cell will help answer the,question, ... pressing questions in the medical research into,P...lls in the brain to die,in the first place. Answer...cause there are two nearly identical types of brai...
(Date:11/12/2008)... - Direct-Acting PRT060128 Provides Reversib...th Immediate Onset of Action -, NEW ORLEANS and S...-,Portola Pharmaceuticals, a biopharmaceutical com...ificant advances in cardiovascular and inflammator...al data that demonstrate,PRT060128, the Company,s ...
(Date:11/12/2008)... MIAMI, Nov. 12 The Miami Jew...egal Institute for Clinical Research today,announc...e CONNECTION,study, a Phase 3 clinical trial that ...tigational drug Dimebon as a treatment for mild-to...estimates from the Alzheimer,s Association, more t...
Breaking Medicine Technology:Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4A Window Into Parkinson's Disease 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 3Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market 778 1New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market 778 2Multi Year Compendium of Pharmaceutical Case Studies Available from Best Practices LLC 776 1Multi Year Compendium of Pharmaceutical Case Studies Available from Best Practices LLC 776 2Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program 774 1Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program 774 2Pharmaceutical Manufacturing Quality 3A Optimizing Your Internal Process for FDA Compliance 772 1Pharmaceutical Manufacturing Quality 3A Optimizing Your Internal Process for FDA Compliance 772 2...WING, N.J.--(BUSINESS WIRE)--Apr 19, 2007 - Antare...lts from a recently completed,site application stu...ATD(TM) transdermal gel, was absorbed on a bioequi...ree different skin site,locations., The study was ...plication site pharmacokinetic study. The trial en...
...XTON, Pa.--(BUSINESS WIRE)--Apr 19, 2007 - Othera ...ker Mousa, Professor of,Pharmacology and Executive... Research Institute at Albany College of Pharmacy,...bserved,antithrombotic effect of Othera,s lead com...work stems from previous ocular,studies on OT-551 ...
Other Medicine Technology:Antares Pharma Announces Positive Results from Application Site,Study for Anturol 2Antares Pharma Announces Positive Results from Application Site,Study for Anturol 3Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 2Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 3Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 4Smooth colibri tip; In Titanium.
Fine .12mm Tip With 5mm Platform; In Titanium.
Curved Shaft with 5mm Platform; 1x2, 0.12 mm teeth; In Titanium.
0.3mm tips; 9.5mm from tips to cross action; in Titanium.
Medicine Products: